Alzheimer's Disease Pilot Clinical Trials (R01)

The objective of the Alzheimers Disease Pilot Clinical Trials initiative is to enable the clinical testing (Phase I and II) of promising pharmacological and non-pharmacological interventions in individuals across the Alzheimer's disease (AD) spectrum from pre-symptomatic to more severe stages of disease, as well as to stimulate studies to enhance trial design and methods.